Tanespimycin in Treating Patients With Stage III-IV Melanoma

Clinical trial NCT00087386 · TERMINATED

Trial details

NCT number: NCT00087386
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Melanoma Stage III Melanoma Stage IV Melanoma

Start date: 2004-06-01
Primary completion: 2007-02-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.